Porcine foot-and-mouth disease virus type a fc polypeptide vaccine and its preparation method and application
A porcine foot-and-mouth disease virus and polypeptide vaccine technology, applied in porcine foot-and-mouth disease virus type A Fc polypeptide vaccine and its preparation, porcine foot-and-mouth disease vaccine and its preparation field, can solve the problems of product lag and long development cycle, and achieve strong immune efficacy and high protection Sexual antibodies, the effect of small differences in antibody levels in immunized animals
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] Example 1. Design and synthesis of swine foot-and-mouth disease virus type A Fc polypeptide
[0025] 1. Design of swine foot-and-mouth disease virus type A polyepitope
[0026] According to the main antigen genes of the three topological strains of swine foot-and-mouth disease virus type A (AF / 72, A / HB / WH / 09, A / GDMM / 2013), the amino acid sequences of 140-160 and 200-213 in the coding region of VP1 gene were selected The amino acid sequence was used as an antigenic epitope, which was then concatenated in the appropriate order, i.e. 140-160(A / GDMM / 2013)-GGSSGG-140-160(A / HBWH / 09)-GPLS-140-160(AF / 72)-GGGS-200-213 (A / GDMM / 2013), in order to prevent the formation of new epitopes after concatenating epitopes, spacer sequences are introduced between adjacent epitopes to ensure the independence of epitopes. The spacers are GGSSGG, GPLS and GGGS. The nucleotide sequence of the obtained swine foot-and-mouth disease virus type A polyepitope is shown in SEQ ID NO.1.
[0027] 2. ...
Embodiment 2
[0031] Example 2. Preparation of Porcine Foot-and-Mouth Disease Virus Type A Fc Polypeptide Vaccine
[0032] The purified swine foot-and-mouth disease virus type A Fc polypeptide prepared in Example 1 was quantified by Bio-Rad quantitative kit and diluted to an appropriate concentration, and the oil adjuvant Montanide ISA206 (Montanide ISA206 ( Seppic, France) was emulsified into a vaccine preparation (W / O / W), 1 ml per head, containing 200 μg of soluble swine foot-and-mouth disease virus type A Fc polypeptide.
Embodiment 3
[0033] Example 3. Immune efficacy test
[0034] The pigs used in the experiment weighed about 40kg, the antibody of type A foot-and-mouth disease virus was less than 1:4 (liquid phase blocking ELISA result), and the 3ABC protein antibody was negative (3ABC antibody chemiluminescence kit result). Five pigs (containing 200 μg of soluble antigen) were inoculated with the Fc polypeptide vaccine of the present invention (prepared in Example 2) by intramuscular route of 1 ml per head. 21 days after priming, all pigs were boosted once with the same dose of vaccine. 14 days after booster immunization, the antibody titer of each pig was determined, together with 3 control pigs with equal conditions in the ABSL-3 laboratory of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, in accordance with the national standard with type A foot-and-mouth disease virus (A / GDMM / 2013 strains) were challenged to pigs and observed for 10 consecutive days. The results sho...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com